Medication info
Klerato Tablet 10mg (Rosuvastatin Calcium)

Klerato Tablet 10mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201900602 · Approved 2019.01.23 · Insurance code 670501240

Summary

Main use
Treatment of dyslipidemia, reduction of cardiovascular risk, and inhibition of atherosclerosis progression
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. The dose may be adjusted as a maintenance dose when a greater reduction in LDL cholesterol is required. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased up to a maximum of 20 mg once daily. 3. Elderly patients : No dose adjustment is required. 4. Patients with renal impairment : No dose adjustment is required in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment. Particular caution is required when administering this medicine at a dose of 20 mg to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. This medicine should not be administered to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.
Children's dosage
Ages 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses greater than 20 mg in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia, reduction of cardiovascular risk, and inhibition of atherosclerosis progression

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • dysbetalipoproteinemia
  • elevated high-sensitivity C-reactive protein levels
  • hypertension
  • low HDL cholesterol level
  • smoking
  • family history of early coronary heart disease
View approved original text

This medication is primarily used as an adjunct to diet for patients with hypercholesterolemia and hyperlipidemia. It helps when dietary and exercise regimens alone are insufficient in patients with primary hypercholesterolemia and mixed hyperlipidemia. It is also used in conjunction with other treatments for patients with homozygous familial hypercholesterolemia. Additionally, it is effective in reducing total cholesterol and LDL cholesterol levels in pediatric patients with familial hypercholesterolemia who meet specific criteria. In adult patients at high risk of cardiovascular disease, it protects cardiovascular health by reducing the risk of stroke, myocardial infarction, and arterial revascularization. Thus, it is used to improve cholesterol levels and reduce the risk of cardiovascular diseases.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. The dose may be adjusted as a maintenance dose when a greater reduction in LDL cholesterol is required. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased up to a maximum of 20 mg once daily. 3. Elderly patients : No dose adjustment is required. 4. Patients with renal impairment : No dose adjustment is required in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment. Particular caution is required when administering this medicine at a dose of 20 mg to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. This medicine should not be administered to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.

Children's dosage

Ages 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses greater than 20 mg in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For instance, individuals who are allergic to this medication, those with severe liver dysfunction, those with muscle disorders, certain kidney diseases, and women who are pregnant or nursing should not take this medication. In addition, caution is advised when using this medication in patients with impaired liver function or high alcohol consumption, individuals with hypothyroidism, elderly patients, and those with a family history of muscle-related diseases. During treatment with this medication, if symptoms such as muscle pain or weakness occur, it is important to inform a doctor immediately, and regular liver function tests or muscle-related examinations are recommended. This medication contains lactose, so individuals with genetic lactose intolerance should not take it. Furthermore, interactions may occur when taken with other medications, so it is crucial to inform your doctor or pharmacist of any other medications being taken. Women who are pregnant or may become pregnant should ensure proper contraceptive measures are in place before taking this medication, as taking it during pregnancy could pose risks to the fetus. In cases of overdose, there is no specific antidote, and treatment should be directed towards symptoms while monitoring liver function and muscle enzyme levels. Lastly, caution should be exercised when driving or operating machinery as dizziness may occur. Finally, this medication can occasionally cause serious skin reactions, liver damage, or muscle damage, so consult a healthcare professional immediately if any unusual symptoms arise.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is also recommended to store it at a temperature between 1 and 30 degrees Celsius to safely maintain the medication's effectiveness.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.